MGMT and neoplasm: Proteomics and in vitro investigations demonstrated that the abundance of SLC38A1 on the plasma membrane is maintained through DSCR3-dependent recycling, resulting in tumor growth and acquired TMZ tolerance in MGMT-deficient GB [103].